Brief: Impel Pharmaceuticals Inc Received Two Written Notifications From Listing Qualifications Department Of Nasdaq
April 17 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS INC - ON APRIL 11, RECEIVED TWO
WRITTEN
NOTIFICATIONS FROM LISTING QUALIFICATIONS DEPARTMENT OF NASDAQ
* IMPEL PHARMACEUTICALS: FIRST NOTIFICATION SAID THAT AS OF
APRIL
11, CO DID NOT MEET $15 MILLION MINIMUM MARKET VALUE OF PUBLICLY
HELD SHARES REQUIREMENT
* IMPEL PHARMACEUTICALS - SECOND NOTIFICATION SAID THAT AS
OF
APRIL 11, CO DID NOT MEET $50 MILLION MINIMUM MARKET VALUE OF
LISTED SECURITIES REQUIREMENT
Source text for Eikon: ID: company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq